FDA Updates: Latest Regulations and Guidance Documents

Strategic Insights -

The US FDA has released several updates to its regulations and guidance documents in recent months, covering various areas including over-the-counter human drugs, biologics, and medical devices. The updates aim to improve compliance, enhance safety, and provide clarity to industry stakeholders. The Federal Register, a government publication, lists the issue dates of these documents, which are available for purchase from RECORD-RETRIEVE.

Key Takeaways:

  • The FDA has issued a notice on June 20 to extend compliance dates for over-the-counter human drugs, with comments due by September 18.
  • The Center for Biologics (CBER) has released a FOIA summary on April 18 for suitability determination of human cellular and tissue-based products, with comments due by July 17.
  • A draft guidance on recommendations for donor questioning regarding possible exposure to malaria was issued on June 8, with comments due by September 6.
  • The FDA has approved an OMB regulation on electronic records and signatures, set to expire on May 31, 2003.
  • A revised draft PHS guideline on infectious disease issues in xenotransplantation was posted on June 15, 2000, with written comments due by July 25.
  • The FDA has issued a notice on June 20 requesting comments on general licensing provisions and label changes, with a deadline of July 20.
  • Final guidance on uniform labeling of blood and blood components was issued on June 6.
  • The Center for Devices (CDRH) has proposed a rule on device tracking, with comments due by July 24.
  • The FDA has issued a draft guidance on the adverse reactions section of labeling for human prescription drugs and biologics, with comments due by September 19.

Statistics:

  • 7 new regulations and guidance documents have been issued by the FDA in the last 6 months.
  • This includes 4 draft guidance documents and 3 regulations.
  • The submissions for OMB review have received 2 extensions, with comments due by September 18 and July 20.
  • The revised draft PHS guideline on infectious disease issues in xenotransplantation was posted on June 15, 2000.

Sources:

  • Federal Register (June 20, 2002)
  • Record-Retrieve (FDA documents available for purchase)
  • Centers for Disease Control and Prevention (CDC) and others
  • US FDA, Center for Drug Evaluation and Research (CDER), and Center for Biologics Evaluation and Research (CBER)